Elenbecestat
Elenbecestat (E2609) is an orally bioavailable, brain-penetrant BACE1 inhibitor for Alzheimer's disease research. It has been investigated in preclinical and clinical studies for its ability to reduce amyloid-beta production in both cellular assays and animal models.
Product Specifications
CAS Number
1388651-30-6
Product Name Alternative
βSecretase, β-Secretase, E2609, E-2609, E 2609, Alzheimer's disease, bSecretase, b-Secretase, BetaSecretase, Beta-secretase, BACE, BACE1, BACE-1, inhibit, Inhibitor, Elenbecestat
Field of Research
Neuroscience
Purity
99.67% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (11.43 mM) ; DMSO:250 mg/mL (571.51 mM)
Smiles
[H][C@]12CSC (N) =N[C@]1 (CO[C@@H]2C) c1cc (NC (=O) c2cnc (cn2) C (F) F) ccc1F
Molecular Formula
C19H18F3N5O2S
Molecular Weight
437.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS001506-20ug 20 µg
Chymotrypsin like protease (CTRL) (NM_001907) Human Over-expression Lysate
Sign In for Pricing
View Details 